AU5594398A - Methods and compositions for preventing and treating bone loss - Google Patents

Methods and compositions for preventing and treating bone loss

Info

Publication number
AU5594398A
AU5594398A AU55943/98A AU5594398A AU5594398A AU 5594398 A AU5594398 A AU 5594398A AU 55943/98 A AU55943/98 A AU 55943/98A AU 5594398 A AU5594398 A AU 5594398A AU 5594398 A AU5594398 A AU 5594398A
Authority
AU
Australia
Prior art keywords
compositions
preventing
methods
bone loss
treating bone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55943/98A
Inventor
Vivian L. Fuh
Keith D Kaufman
Joanne Waldstreicher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9700221.6A external-priority patent/GB9700221D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU5594398A publication Critical patent/AU5594398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
AU55943/98A 1996-12-09 1997-12-05 Methods and compositions for preventing and treating bone loss Abandoned AU5594398A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US3263596P 1996-12-09 1996-12-09
US60032635 1996-12-09
GBGB9700221.6A GB9700221D0 (en) 1997-01-08 1997-01-08 Methods and compositions for preventing and treating bone loss
GB9700221 1997-01-08
US4717497P 1997-05-20 1997-05-20
US60047174 1997-05-20
PCT/US1997/022344 WO1998025623A1 (en) 1996-12-09 1997-12-05 Methods and compositions for preventing and treating bone loss

Publications (1)

Publication Number Publication Date
AU5594398A true AU5594398A (en) 1998-07-03

Family

ID=27268657

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55943/98A Abandoned AU5594398A (en) 1996-12-09 1997-12-05 Methods and compositions for preventing and treating bone loss

Country Status (2)

Country Link
AU (1) AU5594398A (en)
WO (1) WO1998025623A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2324726A (en) * 1997-05-01 1998-11-04 Merck & Co Inc Combination Therapy for the Treatment of Osteoporosis
GB9913649D0 (en) * 1999-06-11 1999-08-11 Karobio Ab Estrogen receptor
US6645974B2 (en) 2001-07-31 2003-11-11 Merck & Co., Inc. Androgen receptor modulators and methods for use thereof
US7402577B2 (en) * 2001-10-03 2008-07-22 Merck & Co., Inc. Androstane 17-beta-carboxamides as androgen receptor modulators
WO2003059293A2 (en) * 2002-01-15 2003-07-24 Merck & Co., Inc. 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators
CA2478186C (en) * 2002-03-13 2011-08-23 Merck & Co., Inc. Fluorinated 4-azasteroid derivatives as androgen receptor modulators
US20050131005A1 (en) * 2002-04-30 2005-06-16 Jiabing Wang 4-azasteroid derivatives as androgen receptor modulators
US20060019989A1 (en) * 2004-07-21 2006-01-26 Steiner Mitchell S Compositions comprising 5-alpha reductase inhibitors and SERMs and methods of use thereof
EP3094323A4 (en) * 2014-01-17 2017-10-11 Ligand Pharmaceuticals Incorporated Methods and compositions for modulating hormone levels
WO2018005608A1 (en) * 2016-06-28 2018-01-04 Northeast Ohio Medical University Compositions and methods for preventing bone loss and/or stimulating bone healing
AU2018354433A1 (en) * 2017-10-27 2020-06-11 XYON Health Inc. Topical formulations for treating dermatological disorders including male pattern baldness

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536716A (en) * 1992-12-11 1996-07-16 Merck & Co., Inc. Spiro piperidines and homologs which promote release of growth hormone
US5578724A (en) * 1994-09-20 1996-11-26 Eli Lilly And Company Process for preparation of benzo[f]quinolinones
US5550134A (en) * 1995-05-10 1996-08-27 Eli Lilly And Company Methods for inhibiting bone loss

Also Published As

Publication number Publication date
WO1998025623A1 (en) 1998-06-18

Similar Documents

Publication Publication Date Title
AU4988997A (en) Compositions and methods for treating bone deficit conditions
AU5081298A (en) Surgical method and composition therefor
AU7471096A (en) Compositions and methods for treating bone deficit conditions
AU1296099A (en) Methods and compositions for treating dermatoses
AU5439996A (en) Compositions and methods for treating pain
AU9214398A (en) Compositions and methods for treating water
AU3387599A (en) Methods and compositions for tissue regeneration
AU1831597A (en) Methods and compositions for inhibiting hexokinase
AU7601198A (en) Natural composition for treating bone or joint inflammation
AU3512295A (en) Composition and method for treating hair
AU2593900A (en) Composition and method for treating glaucoma
HUP9900960A3 (en) Disinfecting compositions and method for disinfecting surfaces
AU6872498A (en) Method and composition for skin treatment
AU8693098A (en) Compositions and methods for treating diabetes
AU2113295A (en) Novel compositions and methods for water treatment
AU4813197A (en) Compositions and methods for treating viral infections
AU3272795A (en) Compositions for treating corns and calluses
AU2327599A (en) Compositions and methods for treating autoimmune diseases
AU2243797A (en) Methods and compositions for inhibiting hexokinase
AU4248597A (en) Methods and compositions for treating preterm labor
GB9621570D0 (en) Formulations and methods for inhibiting bone loss
AU5594398A (en) Methods and compositions for preventing and treating bone loss
AU1714697A (en) Method and composition for the treatment of osteoarthritis
GB9624501D0 (en) Insecticial compositions and method
AU5218398A (en) Compositions for treating soils, method of preparation and use thereof